Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Veerle Surmont

Awards & Distinctions

82 Results

2024

A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma : EORTC 1205

Jo RaskinVeerle SurmontAlexander P.W.M. MaatMaha YahiaSjaak A. BurgersYassin PretzenbacherFrederic De RyckRobin CornelissenHouke M. KlompAna Oliveira et al.

A1 Journal Article in EUROPEAN RESPIRATORY JOURNAL

Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum

Joline IngelsLaurenz De CockDieter StevensRupert MayerFabien Henri TheryGuillem Sanchez SanchezDavid VermijlenKarin WeeningSaskia De SmetNele Lootens et al.

A1 Journal Article in CELL REPORTS MEDICINE

2023

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu SpaasNora SundahlVibeke KruseSylvie RotteyDaan De MaeseneerFréderic DuprezYolande LievensVeerle SurmontLieve BrochezDries Reynders et al.

A1 Journal Article in JAMA ONCOLOGY

Impact of cancer treatment on physical performance in early-stage non-small cell lung cancer

Kirsten QuadfliegEva ArentsSarah HaesevoetsFien HermansMaarten CrielMarc DaenenDavid RuttensMichiel ThomeerMartijn A. SpruitDieter Stevens et al.

MIDRIXNEO-LUNG : safety and immunogenicity of a neoantigen-presenting autologous dendritic cell therapy in resected NSCLC patients

Joline IngelsLaurenz De CockDieter StevensKarin WeeningVeerle SurmontJo Van DorpeFrancis ImpensBjörn MentenKarim VermaelenBart Vandekerckhove

Physical performance of non-small cell lung cancer patients 3 months post treatment initiation compared to healthy peers

Eva ArentsKirsten QuadfliegSarah HaesevoetsFien HermansMaarten CrielMarc DaenenEric DeromDavid RuttensMartijn A. SpruitDieter Stevens et al.

2022

Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome

Malaïka Van der LindenBram Van GaeverLennart RamanKarim VermaelenIngel DemedtsVeerle SurmontUlrike HimpeYolande LievensLiesbeth FerdinandeFranceska Dedeurwaerdere et al.

A1 Journal Article in CANCERS

Health-related quality of life, toxicity and neuro-cognitive functioning : what matters to non-small cell lung cancer patients?

Lotte van der WeijstYolande LievensVeerle Surmont

Neurocognitive functioning following lung cancer treatment : the PRO-Long study

Lotte van der WeijstYolande LievensVeerle SurmontWim Schrauwen

A2 Journal Article in TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der WeijstMiguel E. Aguado-BarreraDavid AzriaPatrick BerkovicPierre BoisselierErik BriersRenée BultijnckPatricia Calvo-CrespoJenny Chang-ClaudeAnanya Choudhury et al.

A1 Journal Article in LUNG CANCER

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der WeijstDavid AzriaPatrick BerkovicPierre BoisselierErik BriersRenée BultijnckJenny Chang-ClaudeAnanya ChoudhuryGilles DefraeneSylvian Demontois et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2021

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report

Lander Van AckerDieter StevensKarim VermaelenVeerle Surmont

A2 Journal Article in JOURNAL OF MEDICAL CASE REPORTS

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries Reynders et al.

A1 Journal Article in BMC CANCER

Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials

Solange PetersSarah DansonDunson EjedepangUrania DafniBaktiar HasanHoi-Shen RadcliffeFrederique BustinJacky CrequitLinda CoateMonica Guillot et al.

A1 Journal Article in LUNG CANCER

Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood

Mick van de WielSofie DerijckeDaniella GaldermansMarc DaenenVeerle SurmontEls De DrooghAnneke LefebureErika SaenenElke VandenbrouckeAnn-Marie Morel et al.

A1 Journal Article in CLINICAL LUNG CANCER

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu SpaasNora SundahlSylvie RotteyVIBEKE KRUSEDaan De MaeseneerFréderic DuprezPiet DirixVeerle SurmontYolande LievensRobin Van den Begin et al.

Lung cancer in Belgium

Sebahat OcakKurt TournoyThierry BerghmansIngel DemedtsRodolphe DurieuxAnnelies JanssensLuigi MorettiKristiaan NackaertsThierry PietersVeerle Surmont et al.

Editorial material

Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study

Lotte van der WeijstVeerle SurmontWim SchrauwenYolande Lievens

A1 Journal Article in FRONTIERS IN ONCOLOGY

2020

A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

M. ReckK. F. MilehamD. A. ClumpL. DecosterA. EstivalE. FelipP. FriedL. Paz-AresM. SebastianN Vinolas Segarra et al.

Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer : results from the Belgian compassionate use program

Sofie JorisThierry PietersAnne SibilleFrederique BustinLaurence JacqminHassan Rezaei KalantariVeerle SurmontJean-Charles GoeminneFrederic ClinckartKarin Pat et al.

A1 Journal Article in JOURNAL OF GERIATRIC ONCOLOGY

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart RamanMalaïka Van der LindenKim Van der EeckenKarim VermaelenIngel DemedtsVeerle SurmontUlrike HimpeFranceska DedeurwaerdereLiesbeth FerdinandeYolande Lievens et al.

A1 Journal Article in GENOME MEDICINE

The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life : a randomised controlled trial

Gaëlle VanbutseleSimon Van BelleVeerle SurmontMARTINE DE LAATRoos ColmanKim EeclooEline NaertMarc De ManKaren GeboesLuc Deliens et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

2019

Coping strategy influences quality of life in patients with advanced lung cancer

Annelies JanssensSofie DerijckeDanny GaldermansVeerle SurmontEls De DrooghAnneke LefebureErika SaenenElke VandenbrouckeAnn-Marie MorelAnna Sadowska et al.

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC

Fabrice BarlesiEdward B. GaronDong-Wan KimEnriqueta FelipJi-Youn HanJoo-Hang KimMyung-Ju AhnMary Jo FidlerMatthew A. GubensJr. de Castro, Gilberto et al.

A1 Journal Article in JOURNAL OF THORACIC ONCOLOGY

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC (vol 14, pg 793, 2019)

F. BarlesiE. B. GaronD-W KimF. EnriquetaJ.Y. HanJ.H. KimM.J. AhnM.J. FidlerM.A. GubensG. de Castro et al.

Health-related quality of life in advanced non-small cell lung cancer : a methodological appraisal based on a systematic literature review

Lotte van der WeijstYolande LievensWim SchrauwenVeerle Surmont

A1 Journal Article in FRONTIERS IN ONCOLOGY

Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Lotte van der WeijstRenée BultijnckAxel Van DammeMarc Van EijkerenVeerle SurmontYolande Lievens

Prognostic understanding and quality of life in patients with advanced lung cancer : a multicenter study

Annelies JanssensSofia DerijckeDanielle GaldermansMarc DaenenVeerle SurmontEls De DrooghAnneke LefebureErika SaenenElke VandenbrouckeAnn-Marie Morel et al.

A1 Journal Article in CLINICAL LUNG CANCER

Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.

Lotte van der WeijstVeerle SurmontWim SchrauwenYolande Lievens

Staging of nutrition disorders in non-small-cell lung cancer patients : utility of skeletal muscle mass assessment

Sami AntounHugues MorelPierre-Jean SouquetVeerle SurmontDavid PlanchardFranck BonnetainPascal FoucherThomas EgenodIvan KrakowskiHelene Gaudin et al.

A1 Journal Article in JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial

RS HerbstP BaasJL Perez-GraciaE FelipD-W KimJ-Y HanJR MolinaJ-H KimC Dubos ArvisM-J Ahn et al.

A1 Journal Article in ANNALS OF ONCOLOGY

2018

A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)

Jo RaskinVeerle SurmontRobin CornelissenPaul BaasPaul EY van SchilJan P van Meerbeeck

A1 Journal Article in TRANSLATIONAL LUNG CANCER RESEARCH

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

Gaëlle VanbutseleKoen PardonSimon Van BelleVeerle SurmontMARTINE DE LAATRoos ColmanKim EeclooVeronique CocquytKaren GeboesLuc Deliens

A1 Journal Article in LANCET ONCOLOGY

Effect of early palliative care : complex intervention and complex results : authors' reply

Gaëlle VanbutseleKoen PardonSimon Van BelleVeerle SurmontMARTINE DE LAATRoos ColmanKim EeclooVeronique CocquytKaren GeboesLuc Deliens

A1 Journal Article in LANCET ONCOLOGY

Invasive aspergillosis mimicking metastatic lung cancer

Michiel VanfleterenAnne-Marie C DingemansVeerle SurmontKarim VermaelenAlida A PostmaAstrid ML Oude lashofCordula CM PitzLizza EL Hendriks

A1 Journal Article in FRONTIERS IN ONCOLOGY

2017

A middle-aged woman with a heavy heart

Cedric Van de BruaeneLara CrapéVeerle Surmont

Editorial material

Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction

PATRICK BERKOVICLeen PaelinckAkos GulybanMarc Van EijkerenVeerle SurmontYolande LievensKatrien Vandecasteele

A1 Journal Article in ACTA ONCOLOGICA

Addressing the palliative setting in advanced lung cancer should not remain a barrier : a multicenter study

Annelies JanssensSofie DerijckeAnneke LefebureElke VandenbrouckeVeerle SurmontDieter CoemanDaniëlle GaldermansAnn-Marie MorelBirgitta I HiddingaJan P van Meerbeeck

A2 Journal Article in CLINICAL LUNG CANCER

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Corinne Faivre-FinnMichael SneeLinda AshcroftWiebke AppelFabrice BarlesiAdityanarayan BhatnagarAndrea BezjakFelipe CardenalPierre FournelSusan Harden et al.

A1 Journal Article in LANCET ONCOLOGY

Health-related quality of life reporting in lung cancer trials : a methodological appraisal

Lotte van der WeijstVeerle SurmontWim SchrauwenYolande Lievens

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?

Lotte van der WeijstVeerle SurmontWim SchrauwenYolande Lievens

A1 Journal Article in CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

2016

Development of a blood test for selection of lung cancer patients who could benefit from immunotherapy.

Malaïka Van der LindenKarim VermaelenIngel DemedtsVeerle SurmontKathleen ClaesBjörn MentenJo Van Dorpe

Palliative care needs at different phases in the illness trajectory : a survey study in patients with cancer

Kim BeernaertKoen PardonLieve Van den BlockD DevroeyMARTINE DE LAATKaren GeboesVeerle SurmontLuc DeliensJoachim Cohen

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Palliative care needs at different phases in the illness trajectory : a survey study in patients with cancer

Kim BeernaertKoen PardonLieve Van den BlockDirk DevroeyMartine De LaatKaren GeboesVeerle SurmontLuc DeliensJoachim Cohen

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Roy S HerbstPaul BaasJose L Perez-GraciaEnriqueta FelipDong-Wan KimJi-Youn HanJulian MolinaJoo-Hang KimCatherine Dubos ArvisMyung-Ju Ahn et al.

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Roy S HerbstPaul BaasJose L Perez-GraciaEnriqueta FelipDong-Wan KimJi-Youn HanJulian MolinaJoo-Hang KimCatherine Dubos ArvisMyung-Ju Ahn et al.

Quality of life in locally-advanced non-small cell lung cancer patients : a systematic review

Lotte van der WeijstWim SchrauwenVeerle SurmontYolande Lievens

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)

Fatma AbdelraoufEgbert SmitBaktiar HasanJessica MenisSanjay PopatJan Van MeerbeeckVeerle SurmontPaul BaasMary O'Brien

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

2015

A phase I study of volasertib combined with afatinib, in advanced solid tumors

Jean-Pascal MachielsMarc PeetersCatherine HerremansVeerle SurmontPol SpecenierMarina De SmetKorinna PilzNatalja StrelkowaDan LiuSylvie Rottey

A1 Journal Article in CANCER CHEMOTHERAPY AND PHARMACOLOGY

Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

PATRICK BERKOVICLeen PaelinckYolande LievensAkos GulybanBRUNO GODDEERISCRISTINA DERIEVeerle SurmontWilfried De NeveKatrien Vandecasteele

A1 Journal Article in ACTA ONCOLOGICA

Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)

Mary ER O'BrienRabab GaafarBaktiar HasanJessica MenisTanja CuferSanjay PopatPenella J WollVeerle SurmontVassilis GeorgouliasAna Montes et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Rehabilitation in patients with radically treated respiratory cancer : a randomised controlled trial comparing two training modalities

Bihiyga SalhiChristel HaenebalckeSilvia Perez-BogerdMai D NguyenVincent NinaneThomas MalfaitKarim VermaelenVeerle SurmontGEORGES VAN MAELERoos Colman et al.

A1 Journal Article in LUNG CANCER

The systematic early integration of palliative care into multidisciplinary oncology care in the hospital setting (IPAC), a randomized controlled trial : the study protocol

Gaëlle VanbutseleSimon Van BelleMARTINE DE LAATVeerle SurmontKaren GeboesKim EeclooKoen PardonLuc Deliens

A1 Journal Article in BMC HEALTH SERVICES RESEARCH

Unresectable stage III non-small-cell lung cancer : have we made any progress?

CAROLIEN DE TOLLENAEREYolande LievensKatrien VandecasteeleKarim VermaelenVeerle Surmont

A2 Journal Article in WORLD JOURNAL OF RESPIROLOGY

2014

EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression

KATRIJN VAN ASSCHELiesbeth FerdinandeYolande LievensKatrien VandecasteeleVeerle Surmont

A2 Journal Article in FRONTIERS IN ONCOLOGY

Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation

Hasan BaktiarLaurent GreillierAthanasios PallisJessica MenisRabab GaafarRichard SylvesterDean A FennellPaul BaasVeerle SurmontJan Van Meerbeeck et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients

Bihiyga SalhiWouter HuysseGEORGES VAN MAELEVeerle SurmontEric DeromJan Van Meerbeeck

A1 Journal Article in LUNG CANCER

2013

Management of malignant pleural mesothelioma: have we made any progress?

BIRGITTA HIDDINGAVeerle SurmontJan Van Meerbeeck

A1 Journal Article in PANMINERVA MEDICA

Outcome and prognostic factors of bronchopulmonary neuroendocrine tumors (BNETS): a single institutional series

Charlotte VerrokenBIRGITTA HIDDINGALiesbeth FerdinandeVeerle SurmontFrederic De RyckKarim VermaelenKaren GeboesJan Van Meerbeeck

Resistance training in patients with radically treated respiratory cancer: a prospective randomized multi-center study (REINFORCE)

Jan Van MeerbeeckBihiyga SalhiC HaenebalckeS Perez-BogerdMD NguyenThomas MalfaitKarim VermaelenVeerle SurmontGEORGES VAN MAELEEric Derom

Resistance training in patients with radically treated respiratory cancer: mature results of a multi-centre randomised phase 3 trial (REINFORCE)

Jan Van MeerbeeckBihiyga SalhiChristel HaenebalckeSylvia Perez-BogerdMay D NguyenThomas MalfaitKarim VermaelenVeerle SurmontGEORGES VAN MAELERoos Colman et al.

Second opinion for thoracic cancer and its impact on diagnosis and treatment strategy: a single institutional series

Thomas MalfaitVeerle SurmontBirgitta I HiddingaKarim VermaelenJan Van Meerbeeck

2012

Activating EGFR mutations in patients with non small cell lung cancer: prevalence and predictors in a caucasian series

Thomas MalfaitLiesbeth FerdinandeKurt TournoyD GaldermansMarleen PraetVeerle SurmontRamses ForsythKarim VermaelenJan Van Meerbeeck

Effect of radical treatment on exercise capacity and muscle force in patients with intrathoracic cancer

Bihiyga SalhiCharlotte HaenebalckeS Perez-BogerdM NguyenKarim VermaelenVeerle SurmontJan Van MeerbeeckEric Derom

Feasibility of epidermal growth factor receptor mutation testing in cytology samples

Thomas MalfaitLiesbeth FerdinandeJan Van MeerbeeckD GaldermansVeerle SurmontRamses ForsythKarim VermaelenMarleen PraetKurt Tournoy

Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future

Mary ER O'BrienJan Van MeerbeeckVeerle SurmontCorinne Faivre Finn

A2 Journal Article in EUROPEAN JOURNAL OF CANCER. SUPPLEMENTS

Treatment of metastatic non-small cell lung cancer: standard of care and future perspectives

Veerle SurmontJan Van Meerbeeck

A2 Journal Article in MINERVA PNEUMOLOGICA

2011

A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)

Rabab M GaafarVeerle SurmontGiorgio V ScagliottiRob J Van KlaverenDemetris PapamichaelJohn J WelchBaktiar HasanValter TorriJan Van Meerbeeck

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Investigational approaches for mesothelioma

Veerle SurmontEric RE Van ThielKarim VermaelenJan Van Meerbeeck

A2 Journal Article in FRONTIERS IN ONCOLOGY

Malignant pleural mesothelioma: the standard of care and challenges for future management

Jan Van MeerbeeckArnaud ScherpereelVeerle SurmontPaul Baas

A1 Journal Article in CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Malignant pleural mesothelioma: when is radiation therapy indicated?

ERE van ThielVeerle SurmontJan Van Meerbeeck

A1 Journal Article in EXPERT REVIEW OF ANTICANCER THERAPY

Raltitrexed in mesothelioma

Veerle SurmontJan Van Meerbeeck

A1 Journal Article in EXPERT REVIEW OF ANTICANCER THERAPY

2010

18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours

Daan De MaeseneerBieke LambertVeerle SurmontKaren GeboesSylvie Rottey

A1 Journal Article in ACTA CLINICA BELGICA

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

Veerle SurmontJGJV AertsRJ van KlaverenK TournoyKY TanRM VernhoutPIM SchmitzC LegrandHC HoogstedenJP van Meerbeeck

A1 Journal Article in ONCOLOGY

Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer

SOFIE DE CRAENEVeerle SurmontJan Van Meerbeeck

A1 Journal Article in CURRENT OPINION IN ONCOLOGY

Endurance and resistance training in radically treated respiratory cancer patients: a pilot study

Bihiyga SalhiIngel DemetsAnn SimpelaereSofie DecraeneKarim VermaelenVeerle SurmontJan Van MeerbeeckEric Derom

A2 Journal Article in REHABILITATION RESEARCH AND PRACTICE

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies

Veerle SurmontEF SmitM de JongeJG AertsK NackaertsR VernhoutJ GrasA Van WijkECJ PhernambucqJP van Meerbeeck et al.

A1 Journal Article in LUNG CANCER

2009

Epidermal growth factor receptor protein expression and gene amplification in Caucasian patients with malignant pleural mesothelioma (MPM)

Veerle SurmontMarleen PraetIsabelle RottiersELISABETH BEERENSBART MATTHYSPatrick PauwelsJan Van Meerbeeck

Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study

Veerle SurmontJoachim AertsE PouwK TanR VernhoutJ GrasJ SalomeT PronkP SchmitzH Hoogsteden et al.

A1 Journal Article in LUNG CANCER

Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments

Jan Van MeerbeeckVeerle Surmont

A1 Journal Article in LUNG CANCER

Trimodality treatment of early stage Malignant Pleural Mesothelioma (MPM): a single institutional experience

Elke VandenbrouckeMarleen PraetKarim VermaelenVeerle SurmontFrederic De RyckKurt TournoyRobert GosselinWilfried De NeveFrank VermassenJan Van Meerbeeck

What is the role for surgery in patients with stage III non-small cell lung cancer ?

Elke VandenbrouckeFrederic De RyckVeerle SurmontJan Van Meerbeeck

A1 Journal Article in Current Opinion in Pulmonary Medicine